Riskpilot← Back to searchSign inGet full accessACVI AB
ABActiveOrg 5591694863Sveavägen 84 Plastikkirurgi Sweden AbMedical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 759K
+717% vs 2024
EBITDA margin
94.5%
+1488% vs 2024
Equity ratio
37.1%
Financial strength
Net profit 2025
SEK 177K
+301% vs 2024
| Revenue | SEK 759K | +717% |
| EBITDA | SEK 718K | +1488% |
| Net profit | SEK 177K | +301% |
| Total assets | SEK 613K | +403% |
| Equity | SEK 227K | +91% |
| Employees | 1 | — |
Legal name
ACVI AB
Org number
5591694863
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 augusti 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Zommorodi, Sayid Sebastian Sam
Company purpose
Företaget kommer att bedriva handel med värdepapper och fastigheter.
Address
Sveavägen 84 Plastikkirurgi Sweden Ab
Email
sayid@akademisktcentrum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 566 | 138 | 42 | 93 | 759 |
| Staff expenses | — | −243 | −42 | −0 | — |
| EBITDA | 533 | −323 | −66 | 45 | 718 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 533 | −323 | −66 | 45 | 718 |
| Net financials | — | −1 | −2 | −1 | −158 |
| Profit before tax | 533 | −324 | −68 | 44 | 177 |
| Tax | −116 | — | — | — | — |
| Net profit | 417 | −324 | −68 | 44 | 177 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 583 | 295 | 116 | 122 | 613 |
| Equity | 467 | 143 | 75 | 119 | 227 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 116 | 153 | 41 | 3 | 386 |
| Total debt | 116 | 153 | 41 | 3 | 386 |
EBITDA margin
94.5%
This company
15.8%
Market median
+498% vs market
20212025
Equity ratio
37.1%
This company
38.2%
Market median
+3% vs market
20212025
Return on equity
78.0%
This company
18.4%
Market median
+324% vs market
20212025
Net profit margin
23.4%
This company
8.1%
Market median
+189% vs market
20212025
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20212025
Debt / equity
1.70×
This company
0.62×
Market median
-174% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ACPK Holding AB
ACVI AB Board members of ACVI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sayid Sebastian Sam Zommorodi | Chief Executive Officer | 0 companies |
| Alexander Arsha Kamali | Chairman | 0 companies |
| Lina Ingalill Johanna Zommorodi | Deputy Board Member | 0 companies |